The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

In other recent news, Trinity Biotech has secured an additional $4 million in debt financing from Perceptive Advisors to advance its continuous glucose monitoring (CGM) technology and ...

In other recent news, Trinity Biotech has secured an additional $4 million in debt financing from Perceptive Advisors to advance its continuous glucose monitoring (CGM) technology and transformation ...

The company aims to use this process to improve the functionality of its glucose biosensor in its next-gen CGM technology. Tuesday, Trinity Biotech plc (NASDAQ:TRIB) stock is trading higher with a ...

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology. For more information, please click on the below link.

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC ...